Biodesix to report fourth quarter and full year 2023 financial results on march 1, 2024

Boulder, colo.--(business wire)---- $bdsx #patientsfirst--biodesix, inc. (nasdaq: bdsx), a leading diagnostic solutions company with a focus in lung disease, announced today that it will release financial results for the fourth quarter and year ended december 31, 2023 before the open of trading on friday, march 1. biodesix's management will host a conference call and webcast to discuss its financial results and provide a general business update at 8:30 a.m. eastern time on the same day. listeners can register for the w.
BDSX Ratings Summary
BDSX Quant Ranking